Format

Send to

Choose Destination
See comment in PubMed Commons below
Expert Rev Anti Infect Ther. 2010 Jul;8(7):791-800. doi: 10.1586/eri.10.59.

Prevention of ventilator-associated pneumonia.

Author information

1
Infection Control Department, Brigham and Women's Hospital, Boston, MA 02115, USA. mklompas@partners.org

Abstract

Ventilator-associated pneumonia (VAP) is an important source of morbidity and mortality in critically ill patients. Many interventions are touted to prevent VAP but studies supporting these interventions are difficult to interpret owing to an exceedingly poor correlation between clinical diagnosis of VAP and the presence of an invasive pneumonia. There is consequently a risk that purported decreases in VAP rates may reflect decreases in oropharyngeal colonization rates more than reductions in invasive disease. To circumvent this source of error, it is critical to assess the impact of intervention measures on patient outcomes rather than on VAP rates alone. This article will review selected VAP prevention methods using this framework and advocate for the development of a new surveillance definition that will more reliably predict patient outcomes.

PMID:
20586564
DOI:
10.1586/eri.10.59
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for Taylor & Francis
    Loading ...
    Support Center